Clozapine REMS Program Paused After Problems With Re-Certification

 
• By Brenda Sandburg
  
Clozapine form
FDA temporarily suspends requirements of clozapine REMS program • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Drug Safety

More from Pink Sheet